These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25494330)

  • 21. [Not Available].
    Kristoffersson U
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29406560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Somatic development of asthmatic children and youth].
    Szilágyi-Pagowska I
    Med Wieku Rozwoj; 2000; 4(2 Suppl 1):5-95. PubMed ID: 11443236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant F8 gene intron 1 inversion with concomitant duplication and deletion in a severe hemophilia A patient from Southern Italy.
    Sanna V; Ceglia C; Tarsitano M; Lombardo B; Coppola A; Zarrilli F; Castaldo G; Di Minno G
    J Thromb Haemost; 2013 Jan; 11(1):195-7. PubMed ID: 23140572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current strategy in colorectal cancer screening].
    Lefter LP; Dajbog E; Scripcariu V; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):753-9. PubMed ID: 16610172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategy for clinical evaluation and screening of sudden cardiac death relatives.
    Ferrero-Miliani L; Holst AG; Pehrson S; Morling N; Bundgaard H
    Fundam Clin Pharmacol; 2010 Oct; 24(5):619-35. PubMed ID: 20698891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded carrier screening: A review of early implementation and literature.
    Lazarin GA; Haque IS
    Semin Perinatol; 2016 Feb; 40(1):29-34. PubMed ID: 26718446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Validation of a Four-Item Migraine Screening Algorithm Among a Nonclinical Sample: The Migraine-4.
    Walters AB; Smitherman TA
    Headache; 2016 Jan; 56(1):86-94. PubMed ID: 26582735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGS-Based Assay for the Identification of Individuals Carrying Recessive Genetic Mutations in Reproductive Medicine.
    Abulí A; Boada M; Rodríguez-Santiago B; Coroleu B; Veiga A; Armengol L; Barri PN; Pérez-Jurado LA; Estivill X
    Hum Mutat; 2016 Jun; 37(6):516-23. PubMed ID: 26990548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing.
    Howell VM; Burnett L
    Lancet; 1996 Mar; 347(9002):685-6. PubMed ID: 8596394
    [No Abstract]   [Full Text] [Related]  

  • 32. Asking the community about cutpoints used to describe mild, moderate, and severe pain.
    Palos GR; Mendoza TR; Mobley GM; Cantor SB; Cleeland CS
    J Pain; 2006 Jan; 7(1):49-56. PubMed ID: 16414555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel classification of knee osteoarthritis severity based on spatiotemporal gait analysis.
    Elbaz A; Mor A; Segal G; Debi R; Shazar N; Herman A
    Osteoarthritis Cartilage; 2014 Mar; 22(3):457-63. PubMed ID: 24418677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening.
    Shraga R; Yarnall S; Elango S; Manoharan A; Rodriguez SA; Bristow SL; Kumar N; Niknazar M; Hoffman D; Ghadir S; Vassena R; Chen SH; Hershlag A; Grifo J; Puig O
    BMC Genet; 2017 Nov; 18(1):99. PubMed ID: 29179688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstetricians should get ready for expanded carrier screening.
    Lau TK
    BJOG; 2016 Sep; 123 Suppl 3():36-8. PubMed ID: 27627595
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of Factor VIII polymorphic markers as a means for carrier detection in Brazilian families with haemophilia A.
    de Carvalho FM; de Vargas Wolfgramm E; Paneto GG; de Paula Careta F; Spagnol Perrone AM; de Paula F; Louro ID
    Haemophilia; 2007 Jul; 13(4):409-12. PubMed ID: 17610558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adding age and genetic risk to PSA test could improve screening for prostate cancer.
    Kmietowicz Z
    BMJ; 2012 Nov; 345():e7467. PubMed ID: 23131672
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current controversies in traditional and expanded carrier screening.
    Lazarin GA; Goldberg JD
    Curr Opin Obstet Gynecol; 2016 Apr; 28(2):136-41. PubMed ID: 26844860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.